VIDEO: OmniVu IOL system shows stability, good refractive predictability
Click Here to Manage Email Alerts
SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Daniel H. Chang, MD, discusses the 12-month results of the first-in-human clinical trial of the OmniVu IOL system from Atia Vision.
The trial assessed the IOL’s impact on both monocular and binocular vision in 21 eyes of 16 patients in India and the Republic of Georgia. Binocular uncorrected visual acuity was at distance 20/16, at intermediate approximately 20/20 and at near about 20/25.
“[It is] a lens with great distance, intermediate and near vision, great range of vision, good contrast and — the biggest thing — refractive predictability,” he said.
Collapse
Chang DH. First-in-human clinical feasibility study of a dual-optic accommodating IOL system. Presented at: American Academy of Ophthalmology meeting; Nov. 3-6, 2023; San Francisco.
Read more about
Click Here to Manage Email Alerts